Muscle Dysfunction in COPD Mechanisms of striated muscle dysfunction during acute exacerbations of COPD
暂无分享,去创建一个
[1] Sally J. Singh,et al. Neuromuscular stimulation of quadriceps in patients hospitalised during an exacerbation of COPD: a comparison of low (35 Hz) and high (50 Hz) frequencies. , 2013, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.
[2] J. Duarte,et al. Mitochondrial signaling contributes to disuse muscle atrophy. , 2012, American journal of physiology. Endocrinology and metabolism.
[3] I. Taylor,et al. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease , 2011, Postgraduate Medical Journal.
[4] S. Powers,et al. Mechanistic links between oxidative stress and disuse muscle atrophy. , 2011, Antioxidants & redox signaling.
[5] Patrick D Mitchell,et al. Hypoxemia in patients with COPD: cause, effects, and disease progression , 2011, International journal of chronic obstructive pulmonary disease.
[6] C. Prefaut,et al. Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study , 2011, European Respiratory Journal.
[7] J. Roca,et al. Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. , 2010, Respiratory medicine.
[8] J. Wedzicha,et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.
[9] M. Mador,et al. Exercise capacity in hamsters with elastase-induced emphysema compared to normal controls , 2010, Respiratory Physiology & Neurobiology.
[10] M. Decramer,et al. Resistance training prevents deterioration in quadriceps muscle function during acute exacerbations of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.
[11] M. Polkey,et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD , 2010, Thorax.
[12] M. Tarnopolsky,et al. Little change in markers of protein breakdown and oxidative stress in humans in immobilization-induced skeletal muscle atrophy. , 2010, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[13] M. Decramer,et al. Gene Expression Profiling in Vastus Lateralis Muscle During an Acute Exacerbation of COPD , 2010, Cellular Physiology and Biochemistry.
[14] R. Balk. Mechanical determinants of early acute ventilatory failure in COPD patients: a physiologic study , 2010 .
[15] J. Thissen,et al. Mechanisms of Muscle Atrophy Induced by Glucocorticoids , 2009, Hormone Research in Paediatrics.
[16] Amie J. Dirks-Naylor,et al. Glucocorticoid-induced apoptosis and cellular mechanisms of myopathy , 2009, The Journal of Steroid Biochemistry and Molecular Biology.
[17] C. Lundby,et al. The response of human skeletal muscle tissue to hypoxia , 2009, Cellular and Molecular Life Sciences.
[18] Stuart M Phillips,et al. Alterations of protein turnover underlying disuse atrophy in human skeletal muscle. , 2009, Journal of applied physiology.
[19] T. Wilson,et al. Effect of acute inflation on the mechanics of the inspiratory muscles. , 2009, Journal of applied physiology.
[20] A. Agustí,et al. Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients , 2009, European Respiratory Journal.
[21] A. Mancha,et al. Nutritional State during COPD Exacerbation: Clinical and Prognostic Implications , 2009, Annals of Nutrition and Metabolism.
[22] J. Steurer,et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. , 2009, The Cochrane database of systematic reviews.
[23] P. Tesch,et al. Skeletal muscle proteolysis in response to short-term unloading in humans. , 2008, Journal of applied physiology.
[24] D. Freyssenet,et al. Cellular and molecular events controlling skeletal muscle mass in response to altered use , 2008, Pflügers Archiv - European Journal of Physiology.
[25] M. Decramer,et al. Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients , 2007, European journal of clinical investigation.
[26] B. Celli,et al. Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.
[27] J. Barberà,et al. Mitochondrial dysfunction in COPD patients with low body mass index , 2007, European Respiratory Journal.
[28] M. Polkey,et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease , 2007, Respiratory research.
[29] B. Celli,et al. Impact of COPD exacerbations on patient-centered outcomes. , 2007, Chest.
[30] D. O’Donnell,et al. COPD exacerbations · 3: Pathophysiology , 2006, Thorax.
[31] Thierry Troosters,et al. Physical activity and hospitalization for exacerbation of COPD. , 2006, Chest.
[32] W. Reid,et al. Increased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations , 2006, European Respiratory Journal.
[33] M. Decramer,et al. IL-8 administration does not result in skeletal muscle wasting in rats , 2006 .
[34] C. Prefaut,et al. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress , 2005, European Respiratory Journal.
[35] N. Murphy,et al. Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. , 2005, Respiratory medicine.
[36] N. Ambrosino,et al. Lung and respiratory muscle function at discharge from a respiratory intensive care unit. , 2005, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[37] M. Martínez-García,et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.
[38] M. Reid. Response of the ubiquitin-proteasome pathway to changes in muscle activity. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[39] John R Hurst,et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[40] M. Decramer,et al. Interleukin-6 Causes Myocardial Failure and Skeletal Muscle Atrophy in Rats , 2005, Circulation.
[41] E. Wouters,et al. Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial. , 2004, Clinical nutrition.
[42] Thierry Troosters,et al. Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. , 2004, Chest.
[43] M. Delp,et al. Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters , 2004, European Respiratory Journal.
[44] C. Lundby,et al. Oxidative DNA damage and repair in skeletal muscle of humans exposed to high-altitude hypoxia. , 2003, Toxicology.
[45] M. Engelen,et al. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[46] M. Decramer,et al. CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003 .
[47] C. Fracchia,et al. Peripheral Muscle Strength Training in Bed‐Bound Patients with COPD Receiving Mechanical Ventilation: Effect of Electrical Stimulation. , 2003, Chest.
[48] J. Wedzicha,et al. COPD exacerbations: definitions and classifications , 2003, European Respiratory Journal.
[49] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[50] M. Lewis. Apoptosis as a potential mechanism of muscle cachexia in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.
[51] S. Quintana,et al. Mortality after hospitalization for COPD. , 2002, Chest.
[52] J. Gea,et al. Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[53] M. Elliott,et al. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.
[54] E. Wouters,et al. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations , 2001, Thorax.
[55] N. Anthonisen,et al. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.
[56] F. López‐Soriano,et al. The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. , 2000, European cytokine network.
[57] R. Ferrari,et al. Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes , 2000, Heart.
[58] T. Seemungal,et al. Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.
[59] R. Rodríguez-Roisín,et al. Toward a consensus definition for COPD exacerbations. , 2000, Chest.
[60] E. Wouters,et al. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[61] Who Consultation on Obesity. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. , 2000, World Health Organization technical report series.
[62] J. Thissen,et al. Regulation of IGF‐I, IGFBP‐4 and IGFBP‐5 gene expression by loading in mouse skeletal muscle , 1999, FEBS letters.
[63] P. Mozdziak,et al. Myogenin, MyoD, and myosin heavy chain isoform expression following hindlimb suspension. , 1999, Aviation, space, and environmental medicine.
[64] M. Decramer,et al. Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. , 1999, American journal of respiratory and critical care medicine.
[65] T. Seemungal,et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[66] E. Wouters,et al. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. , 1997, The European respiratory journal.
[67] J. Martin,et al. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[68] R E Grindeland,et al. Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. , 1997, The American journal of physiology.
[69] W. MacNee,et al. Prognostic significance of plasma D-dimer levels in patients with lung cancer. , 1997, Thorax.
[70] J. Barberà,et al. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. , 1997, The European respiratory journal.
[71] M. Mador,et al. Effect of acute hypercapnia on diaphragmatic and limb muscle contractility. , 1997, American journal of respiratory and critical care medicine.
[72] M. Decramer,et al. Muscle weakness is related to utilization of health care resources in COPD patients. , 1997, The European respiratory journal.
[73] L Goldman,et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.
[74] W. MacNee,et al. Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.
[75] M. Decramer,et al. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[76] R. Wolfe,et al. Prolonged bed rest decreases skeletal muscle and whole body protein synthesis. , 1996, The American journal of physiology.
[77] J. Curtis,et al. Emergent assessment and management of acute respiratory failure in COPD. , 1994, Clinics in chest medicine.
[78] K. Pandolf,et al. Adductor pollicis muscle fatigue during acute and chronic altitude exposure and return to sea level. , 1994, Journal of applied physiology.
[79] M. Decramer,et al. Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered. , 1992, The European respiratory journal.
[80] J. Moxham,et al. Effect of acute hypercapnia on limb muscle contractility in humans. , 1990, Journal of applied physiology.
[81] S C Gandevia,et al. Inspiratory and skeletal muscle strength and endurance and diaphragmatic activation in patients with chronic airflow limitation. , 1989, Thorax.
[82] E. Fiaccadori,et al. Intracellular acid-base and electrolyte metabolism in skeletal muscle of patients with chronic obstructive lung disease and acute respiratory failure. , 1986, Clinical science.
[83] P. Calverley,et al. Effect of Carbon Dioxide on Diaphragmatic Function in Human Beings , 1984 .
[84] A. Grassino,et al. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.
[85] G. Hedenstierna,et al. Muscle metabolism in patients with chronic obstructive lung disease and acute respiratory failure. , 1977, Clinical science and molecular medicine.